Outpatient Surgery Quality and Access Act of 2023

H.R. 8702/S. 4532 Improving Seniors Timely Access to Care Act of 2024 H.R. 972/ S. 312 Outpatient Surgery Quality and Access Act of 2023

Client expense: $45,000 · Firm income: Not reported

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023. Price Transparency Legislation: Lower Costs, More Transparency Act (H.R. 5378) and Health Care PRICE Transparency Act 2.0(S. 3548) Issues regarding TRICARE reimbursement Proposed prior authorization demonstration project (Centers for Medicare & Medicaid Services)

Client expense: $105,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 8702/S. 4532 Improving Seniors Timely Access to Care Act of 2024 H.R. 972/ S. 312 Outpatient Surgery Quality and Access Act of 2023

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, and S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024 Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 972, S. 312 - Outpatient Surgery Quality and Access Act of 2023: Provisions related to Medicare beneficiary access to procedures performed in ambulatory surgical centers. Issues related to Medicare beneficiary access to treatments for depression.

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Save the DA Act Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) S.312/H.R.972 Outpatient Surgery Quality and Access Act of 2023 Medicaid Fiscal Accountability Regulation (MFAR) S. 2840: Bipartisan Primary Care and Health Workforce Act ACA premium tax credits

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Save the DA Act Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) S.312/H.R.972 Outpatient Surgery Quality and Access Act of 2023 Medicaid Fiscal Accountability Regulation (MFAR) S. 2840: Bipartisan Primary Care and Health Workforce Act ACA premium tax credits

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MMM: HR 972 and S312, Medicare beneficiary access to procedures performed in ambulatory surgical centers; ENV: EPA regulation of medical device sterilization; MMM: Medicare beneficiary access to treatments for depression; HCR: Issues related to epilepsy, issues related to telehealth.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 972, S. 312 - Outpatient Surgery Quality and Access Act of 2023: Provisions related to Medicare beneficiary access to procedures performed in ambulatory surgical centers. Issues related to Medicare beneficiary access to treatments for depression.

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Save the DA Act Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) S.312/H.R.972 Outpatient Surgery Quality and Access Act of 2023 Medicaid Fiscal Accountability Regulation (MFAR) S. 2840: Bipartisan Primary Care and Health Workforce Act ACA premium tax credits

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Save the DA Act Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) S.312/H.R.972 Outpatient Surgery Quality and Access Act of 2023 Medicaid Fiscal Accountability Regulation (MFAR) S. 2840: Bipartisan Primary Care and Health Workforce Act ACA premium tax credits

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023. Price Transparency Legislation: Lower Costs, More Transparency Act (H.R. 5378) and Health Care PRICE Transparency Act 2.0(S. 3548) Issues regarding TRICARE reimbursement Proposed prior authorization demonstration project (Centers for Medicare & Medicaid Services)

Client expense: $105,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 8702/S. 4532 Improving Seniors Timely Access to Care Act of 2024 H.R. 972/ S. 312 Outpatient Surgery Quality and Access Act of 2023

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 972, S. 312 - Outpatient Surgery Quality and Access Act of 2023: Provisions related to Medicare beneficiary access to procedures performed in ambulatory surgical centers. Issues related to Medicare beneficiary access to treatments for depression.

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Save the DA Act Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) S.312/H.R.972 Outpatient Surgery Quality and Access Act of 2023 Medicaid Fiscal Accountability Regulation (MFAR) S. 2840: Bipartisan Primary Care and Health Workforce Act Site Neutral ACA premium tax credits

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Hospital and physician payments under Medicare and Medicaid, general. Medicare/ Medicaid Reform- (Bundling of Medicare acute and post-acute hospital payments, payments for readmissions, value-based purchasing, physician self-referral)- Implementation of the Health Care and Education Reconciliation Act of 2012 (Pub. Law 111-143). Medicare site neutral payments Federal exchange subsidies under The Affordable Care Act Medicare and Medicaid Disproportionate Share Hospital funding Accountable Care Organization (ACO) programs CHGME ACA Stabilization Price Transparency Save the DA Act Telehealth 340B Medicare payment policy: IPPS/OPPS Graduate Medical Education (GME) S.312/H.R.972 Outpatient Surgery Quality and Access Act of 2023 Medicaid Fiscal Accountability Regulation (MFAR) S. 2840: Bipartisan Primary Care and Health Workforce Act Site Neutral ACA premium tax credits

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Issues relating to telemedicine waivers; Customs regulations governing medical device imports (HCR); Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 972; S 312) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy and depression (VET); EPA regulation of medical device sterilization (ENV); Medicare Beneficiary access to treatments for depression (MMM); Issues related to epilepsy (HCR)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to telemedicine waivers; Customs regulations governing medical device imports (HCR); Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 972; S 312) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy and depression (VET); EPA regulation of medical device sterilization (ENV); Medicare Beneficiary access to treatments for depression (MMM); Issues related to epilepsy (HCR)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to telemedicine waivers; Customs regulations governing medical device imports (HCR); Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 972; S 312) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy and depression (VET); EPA regulation of medical device sterilization (ENV); Medicare Beneficiary access to treatments for depression (MMM); Issues related to epilepsy (HCR)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to telemedicine waivers; Customs regulations governing medical device imports (HCR); Medicare beneficiary access to procedures performed in ambulatory surgical centers (HR 972; S 312) (MMM); Veterans access to innovative medical technologies (VET); Supporting appropriate care for veterans with epilepsy and depression (VET); EPA regulation of medical device sterilization (ENV); Medicare Beneficiary access to treatments for depression (MMM); Issues related to epilepsy (HCR)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act; Medicare beneficiary access to treatments for depression

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023. Price Transparency Legislation: Lower Costs, More Transparency Act (H.R. 5378) and Health Care PRICE Transparency Act 2.0(S. 3548) Issues regarding TRICARE reimbursement Proposed prior authorization demonstration project (Centers for Medicare & Medicaid Services)

Client expense: $105,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Access Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE